MAPT and Alzheimer disease: Furthermore, VCP levels are reduced in postmortem AD patient brains, where they inversely correlate with a marker of phosphorylated tau, and VCP overexpression in a viral-driven tau mouse model suppresses tau pathology (Giong et al. 2024).